CDSCO लाइसेंस उल्लंघन पर जुर्माना
Definition
Mandatory cosmetic manufacturing license from SLA under CDSCO; failure results in legal troubles, penalties, and license revocation. New rules mandate batch-wise testing and record-keeping, with strict punitive actions for non-compliance.
Key Findings
- Financial Impact: ₹2,500 license fee + ₹1,000 inspection fee per application; penalties include license suspension leading to production halts (estimated ₹5-10 lakhs per incident based on statutory fees and downtime).
- Frequency: Per manufacturing site and product category renewal.
- Root Cause: Manual site inspections, GMP non-adherence, inadequate batch testing.
Why This Matters
The Pitch: Personal Care manufacturers in India 🇮🇳 risk ₹10,00,000+ in fines and recalls per violation. Automation of compliance tracking eliminates this risk.
Affected Stakeholders
Manufacturing Head, Compliance Officer, QA Manager
Deep Analysis (Premium)
Financial Impact
Financial data and detailed analysis available with full access. Unlock to see exact figures, evidence sources, and actionable insights.
Current Workarounds
Financial data and detailed analysis available with full access. Unlock to see exact figures, evidence sources, and actionable insights.
Get Solutions for This Problem
Full report with actionable solutions
- Solutions for this specific pain
- Solutions for all 15 industry pains
- Where to find first clients
- Pricing & launch costs
Methodology & Sources
Data collected via OSINT from regulatory filings, industry audits, and verified case studies.
Related Business Risks
GMP अनुपालन और बैच टेस्टिंग की अधिक लागत
लेबलिंग त्रुटियों से रिकॉल और रीवर्क
शेल्फ-लाइफ टेस्टिंग विफलता से उत्पाद अस्वीकृति
स्थिरता परीक्षण पर अनावश्यक व्यय
शेल्फ-लाइफ गलत घोषणा पर जुर्माना
समाप्ति तिथि फर्जीवाड़ा से इन्वेंटरी हानि
Request Deep Analysis
🇮🇳 Be first to access this market's intelligence